Evaluation of Guillain-Barre Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001

被引:43
作者
Burwen, Dale R. [1 ]
Ball, Robert [1 ]
Bryan, Wilson W. [2 ]
Izurieta, Hector S. [1 ]
La Voie, Lawrence [5 ,6 ]
Gibbs, Neville A. [2 ]
Kliman, Rebecca [3 ,4 ]
Braun, M. Miles [1 ]
机构
[1] US FDA, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA
[2] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[3] Ctr Medicare, Qual Improvement Grp, Off Clin Stand & Qual, Baltimore, MD USA
[4] Ctr Medicaid Serv, Qual Improvement Grp, Off Clin Stand & Qual, Baltimore, MD USA
[5] Ctr Medicare, Kansas City Reg Off, Kansas City, MO USA
[6] Ctr Medicare, Kansas City Reg Off, Kansas City, MO USA
关键词
UNITED-STATES; ASSOCIATION; IMMUNIZATION; SURVEILLANCE; FEATURES; CRITERIA; SAFETY; SWEDEN;
D O I
10.1016/j.amepre.2010.05.022
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The 1976-1977 swine influenza vaccine was associated with an elevated risk of Guillain-Barre Syndrome (GBS), especially within 6 weeks after vaccination. A 2004 IOM report concluded that evidence was inadequate to accept or reject a causal relationship between subsequent influenza vaccine formulations and GBS. Studies published after the IOM report have been limited by passively reported data or lack of validation of coded diagnoses. Purpose: To evaluate whether influenza vaccine is associated with GBS. Methods: Controlled observational study using national data from the Medicare program, which ensures a predominantly elderly population. People included had a Medicare claim for influenza vaccination during September-December in 2000 or 2001. Medical records were reviewed to classify definite, probable, or possible GBS (or not a case) using a standardized case definition. In a risk interval design, the incidence rate of GBS during Weeks 0-6 after vaccination (exposed period) was compared to Weeks 9-14 after vaccination (comparison period). Data collection occurred during 2003-2007, and analysis was conducted during 2007-2009. Results: Primary analysis included 22.2 million vaccinees, among whom 164 definite or probable GBS cases with onset during Weeks 0-6 or 9-14 were identified. The incidence rate ratio (IRR [95% CIs]) based on the GBS rate in the vaccine-exposed versus comparison periods, was 1.04 (0.76, 1.43) for combined years; 0.86 (0.52, 1.41) among people vaccinated in 2000; and 1.21 (0.79, 1.86) among people vaccinated in 2001. Secondary analysis additionally included 74 possible GBS cases; results were similar. Conclusions: Overall, the results do not support an association between influenza vaccine receipt and GBS among the elderly for the years studied (2000-2001 and 2001-2002 formulations). (Am J Prev Med 2010;39(4):296-304) Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine
引用
收藏
页码:296 / 304
页数:9
相关论文
共 40 条
[21]   Clinical and epidemiologic features of Guillain-Barre syndrome [J].
Hughes, RAC ;
Rees, JH .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 :S92-S98
[22]   No association between immunization and Guillain-Barre syndrome in the United Kingdom, 1992 to 2000 [J].
Hughes, Richard A. ;
Charlton, Judith ;
Latinovic, Radoslav ;
Gulliford, Martin C. .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (12) :1301-1304
[23]  
*IOM, 2001, IMM SAF REV INFL VAC
[24]  
*IOM, 2001, IMM SAF REV INFL VAC, P78
[25]  
*IOM, 2001, IMM SAF REV INF VACC, P88
[26]   Guillain-Barre syndrome after influenza vaccination in adults - A population-based study [J].
Juurlink, David N. ;
Stukel, Therese A. ;
Kwong, Jeffrey ;
Kopp, Alexander ;
McGeer, Allison ;
Upshur, Ross E. ;
Manuel, Douglas G. ;
Moineddin, Rahim ;
Wilson, Kumanan .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (20) :2217-2221
[27]   GUILLAIN-BARRE-SYNDROME IN THE UNITED-STATES, 1979-1980 AND 1980-1981 - LACK OF AN ASSOCIATION WITH INFLUENZA VACCINATION [J].
KAPLAN, JE ;
KATONA, P ;
HURWITZ, ES ;
SCHONBERGER, LB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (06) :698-700
[28]   GUILLAIN-BARRE-SYNDROME IN THE UNITED-STATES, 1978-1981 - ADDITIONAL OBSERVATIONS FROM THE NATIONAL SURVEILLANCE SYSTEM [J].
KAPLAN, JE ;
SCHONBERGER, LB ;
HURWITZ, ES ;
KATONA, P .
NEUROLOGY, 1983, 33 (05) :633-637
[29]   FATAL GUILLAIN-BARRE-SYNDROME AFTER THE NATIONAL INFLUENZA IMMUNIZATION PROGRAM [J].
KEENLYSIDE, RA ;
SCHONBERGER, LB ;
BREGMAN, DJ ;
BOLYAI, JZS .
NEUROLOGY, 1980, 30 (09) :929-933
[30]   AN EPIDEMIOLOGIC AND CLINICAL-EVALUATION OF GUILLAIN-BARRE-SYNDROME REPORTED IN ASSOCIATION WITH THE ADMINISTRATION OF SWINE INFLUENZA VACCINES [J].
LANGMUIR, AD ;
BREGMAN, DJ ;
KURLAND, LT ;
NATHANSON, N ;
VICTOR, M .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1984, 119 (06) :841-879